Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Feb 9, 2015Agreement Extends Reach of Lutonix DCB and Provides Physicians with a Comprehensive Solution to Prepare and Treat Diseased Femoropopliteal VesselsAgreement provides physicians with a comprehensive solution to prepare and treat diseased femoropopliteal vessels
Feb 4, 2015"2014 was another year of significant achievement for Boston Scientific," said Mike Mahoney, chairman and CEO
Feb 2, 2015Implantable cardioverter defibrillators projected to last nearly 12 years, double the battery capacity of other ICDs
-
Dec 12, 2014Significant Relief Achieved Using Advanced Illumina™ 3D Programming Software
Significant relief achieved using Advanced Illumina™ 3D programming software
-
Nov 19, 2014EVOLVE II Trial Represents the First Successful U.S. Pivotal Trial of a Bioabsorbable Polymer Stent
EVOLVE II trial represents the first successful U.S. pivotal trial of a bioabsorbable polymer stent
-
Nov 17, 2014
System designed for the hysteroscopic removal of interuterine fibroids and polyps
-
Nov 13, 2014New CPT Category I Code Facilitates Processing for U.S. Hospitals and Physicians
New CPT Category I code facilitates processing for U.S. hospitals and physicians
-
Nov 3, 2014Data Will Focus on Long-Term Back Pain Relief Using the Boston Scientific Precision Spectra™ Spinal Cord Stimulator (SCS) System and Highlight Research on Stimulation Waveforms
Data will focus on long-term back pain relief using the Precision Spectra™ Spinal Cord Stimulator (SCS) System and highlight research on stimulation waveforms
-
Oct 22, 2014
"We achieved excellent third quarter results,” said Mike Mahoney, Boston Scientific chairman and CEO
-
Oct 21, 2014World's First 32-contact SCS Surgical Leads Designed to Provide More Focused Pain Relief for Patients with Chronic Pain
World's first 32-contact SCS surgical leads designed to provide more focused pain relief for patients with chronic pain